Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2025 Results on April 22, 2025
Elevance Health (NYSE: ELV) has announced it will release its first quarter 2025 financial results on April 22, 2025, at 6:00 a.m. EDT. The company will host a conference call at 8:30 a.m. EDT the same day to discuss the results and outlook.
Participants can access the call using the following numbers:
- Domestic: 888-947-9963 (Access Code: 3972058)
- International: 312-470-0178 (Access Code: 3972058)
A replay will be available from 11:30 a.m. EDT on April 22 until May 22, 2025, through:
- Domestic: 800-396-1242
- International: 203-369-3272
Elevance Health (NYSE: ELV) ha annunciato che rilascerà i suoi risultati finanziari del primo trimestre 2025 il 22 aprile 2025, alle 6:00 a.m. EDT. L'azienda ospiterà una conferenza telefonica alle 8:30 a.m. EDT nello stesso giorno per discutere i risultati e le prospettive.
I partecipanti possono accedere alla chiamata utilizzando i seguenti numeri:
- Nazionali: 888-947-9963 (Codice di Accesso: 3972058)
- Internazionali: 312-470-0178 (Codice di Accesso: 3972058)
Una registrazione sarà disponibile dalle 11:30 a.m. EDT del 22 aprile fino al 22 maggio 2025, tramite:
- Nazionali: 800-396-1242
- Internazionali: 203-369-3272
Elevance Health (NYSE: ELV) ha anunciado que publicará sus resultados financieros del primer trimestre de 2025 el 22 de abril de 2025, a las 6:00 a.m. EDT. La empresa llevará a cabo una conferencia telefónica a las 8:30 a.m. EDT el mismo día para discutir los resultados y las perspectivas.
Los participantes pueden acceder a la llamada utilizando los siguientes números:
- Nacional: 888-947-9963 (Código de Acceso: 3972058)
- Internacional: 312-470-0178 (Código de Acceso: 3972058)
Una grabación estará disponible desde las 11:30 a.m. EDT del 22 de abril hasta el 22 de mayo de 2025, a través de:
- Nacional: 800-396-1242
- Internacional: 203-369-3272
엘리번스 헬스 (NYSE: ELV)는 2025년 1분기 재무 결과를 2025년 4월 22일 오전 6시(EDT)에 발표할 것이라고 발표했습니다. 회사는 같은 날 오전 8시 30분(EDT)에 결과 및 전망에 대해 논의하기 위한 컨퍼런스 콜을 개최할 예정입니다.
참가자는 다음 번호를 사용하여 전화를 접속할 수 있습니다:
- 국내: 888-947-9963 (접속 코드: 3972058)
- 국제: 312-470-0178 (접속 코드: 3972058)
재생은 4월 22일 오전 11시 30분(EDT)부터 2025년 5월 22일까지 다음을 통해 제공됩니다:
- 국내: 800-396-1242
- 국제: 203-369-3272
Elevance Health (NYSE: ELV) a annoncé qu'il publiera ses résultats financiers du premier trimestre 2025 le 22 avril 2025 à 6h00 EDT. L'entreprise organisera une conférence téléphonique le même jour à 8h30 EDT pour discuter des résultats et des perspectives.
Les participants peuvent accéder à l'appel en utilisant les numéros suivants:
- National: 888-947-9963 (Code d'accès: 3972058)
- International: 312-470-0178 (Code d'accès: 3972058)
Un enregistrement sera disponible à partir de 11h30 EDT le 22 avril jusqu'au 22 mai 2025, via:
- National: 800-396-1242
- International: 203-369-3272
Elevance Health (NYSE: ELV) hat bekannt gegeben, dass es am 22. April 2025 um 6:00 Uhr EDT seine Finanzergebnisse für das erste Quartal 2025 veröffentlichen wird. Das Unternehmen wird am selben Tag um 8:30 Uhr EDT eine Telefonkonferenz abhalten, um die Ergebnisse und die Aussichten zu besprechen.
Teilnehmer können die Konferenz unter den folgenden Nummern erreichen:
- Inland: 888-947-9963 (Zugangscode: 3972058)
- International: 312-470-0178 (Zugangscode: 3972058)
Eine Aufzeichnung wird von 11:30 Uhr EDT am 22. April bis zum 22. Mai 2025 verfügbar sein, über:
- Inland: 800-396-1242
- International: 203-369-3272
- None.
- None.
- 888-947-9963 – Access Code - 3972058 (Domestic)
- 312-470-0178 – Access Code - 3972058 (International)
- 800-396-1242 – No Access Code (Domestic Replay)
- 203-369-3272 – No Access Code (International Replay)
The replay will be available from 11:30 a.m. EDT on April 22, 2025, until the end of the day on May 22, 2025. The call will also be available through a live webcast at www.elevancehealth.com under the “Investors” link. You may also access the webcast here. A webcast replay will be available following the call.
About Elevance Health
Elevance Health is a lifetime, trusted health partner whose purpose is to improve the health of humanity. The company supports consumers, families, and communities across the entire healthcare journey – connecting them to the care, support, and resources they need to lead better lives. Elevance Health’s companies serve approximately 112 million consumers through a diverse portfolio of industry-leading medical, pharmacy, behavioral, clinical, home health and complex care solutions. For more information, please visit www.elevancehealth.com or follow us @ElevanceHealth on X and Elevance Health on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250331684682/en/
Investor Relations:
Nathan Rich
Investor.Relations@elevancehealth.com
Media Relations:
Leslie Porras
Leslie.Porras@elevancehealth.com
Source: Elevance Health, Inc.